The British Journal of Rheumatology, Vol 37, 972-977, Copyright © 1998 by British Society for Rheumatology
MR Gonzalez-Crespo, JA Navarro, J Arenas, E Martin-Mola, J De La Cruz and JJ Gomez- Reino
OBJECTIVE: To study prospectively whether serum and urinary nitrate levels
are related to lupus activity. METHODS: Fifty patients with systemic lupus
erythematosus (SLE) were studied prospectively for 2 yr. Every 4 months,
the SLE Disease Activity Index (SLEDAI) was administered to the patients,
and blood and 24 h urine samples were obtained; 88 healthy controls were
also studied. Nitrate levels were measured by the Greiss method.
Statistical analyses were performed using standard parametric and
non-parametric tests, and analysis of serial measurements. RESULTS: Twelve
patients suffered infections, 12 active nephritis and 17 episodes of
non-renal activity. By analysis of serial measurements, serum and urinary
nitrate levels did not correlate with SLEDAI. C-Reactive protein (CRP)
levels, presence of infection and creatinine clearance weakly influenced
nitrate levels. CONCLUSIONS: In SLE, serum and urinary nitrate levels do
not parallel lupus activity. Other variables, related or not to SLE, seem
to affect these levels.
ORIGINAL PAPERS
Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus
Rheumatology Unit, Hospital Universitario Doce de Octubre, Madrid, Spain.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. Vazgiourakis, P. Sidiropoulos, G. Bertsias, E. Koutsounaki, E. Fragouli, A. Raptopoulou, H. Kritikos, D.T. Boumpas, and G.N. Goulielmos Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population Lupus, November 1, 2007; 16(11): 867 - 874. [Abstract] [PDF] |
||||
![]() |
M. A. Lopez-Nevot, L. Ramal, J. Jimenez-Alonso, and J. Martin The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus Rheumatology, January 1, 2003; 42(1): 113 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Ho, C. K. Wong, E. K. Li, L. S. Tam, and C. W. K. Lam Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus Rheumatology, January 1, 2003; 42(1): 117 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S L Lui, R Tsang, D Wong, K W Chan, T M Chan, P C W Fung, and K N Lai Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice Lupus, July 1, 2002; 11(7): 411 - 418. [Abstract] [PDF] |
||||

